HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

V Ragosch Selected Research

Letrozole (Femara)

2/2012Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer - results of the eLEcTRA trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


V Ragosch Research Topics

Disease

2Breast Neoplasms (Breast Cancer)
02/2012 - 07/2004
1Neoplasms (Cancer)
02/2012
1Hemorrhage
06/2001
1Placenta Previa
06/2001

Drug/Important Bio-Agent (IBA)

1Hormones (Hormone)IBA
02/2012
1Letrozole (Femara)FDA LinkGeneric
02/2012
1Trastuzumab (Herceptin)FDA Link
02/2012
111-beta-Hydroxysteroid Dehydrogenase Type 2 (11 beta-Hydroxysteroid Dehydrogenase Type 2)IBA
07/2004

Therapy/Procedure

1Cesarean Section (Caesarean Section)
06/2001